Ophthalmic uses of SIP receptor modulators

Details for Australian Patent Application No. 2012202709 (hide)

Owner Novartis AG

Inventors Lambrou, George N.; Latour, Elisabeth Jeanne

Agent Davies Collison Cave

Pub. Number AU-A-2012202709

Parent 2010202185

Filing date 9 May 2012

Wipo publication date 31 May 2012

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

24 May 2012 Complete Application Filed

31 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202709

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202710-Quinoline derivatives as P13 kinase inhibitors

2012202708-Continuous production of baked products